Hypoxia & Cell Fate · Oxygen sensing in cardiovascular progenitors cell fate decisions
7РП — „Хора“ (Действия „Мария Кюри“)
- Период
- 2011-03-01 → 2015-02-28
- Финансиране от ЕС
- 100 000 €
- Участници
- 1
- Схема
- MC-IRG
Линиите свързват координатора с партньорите.
Накратко на български
Нивата на кислород влияят върху това дали стволовите клетки на сърцето ще се умножават или ще се превърнат в мускулни тъкани. Разбирането на този процес помага да се разбере как се формират сърдечните камери и как се развива сърцето при ембриона.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
Oxygen sensing in cardiovascular progenitors cell fate decisions
Cardiogenesis is a complex process that requires the maturation of different cardiovascular progenitors to compose the final functional compartments of the heart. Cardiac development takes place under low oxygen conditions but the direct function of hypoxia during cardiogenesis is mostly unknown. The main goal of this project is to characterize the role of embryonic hypoxia in cardiovascular development and homeostasis, specially at the level of early mesodermal and epicardial progenitors. By means of embryonic stem cells and characterization of several mouse models of loss (LOF) and gain of function (GOF) we have determined that low oxygen tensions repress second heart field (SHF) mesodermal progenitors proliferation and at the time promotes differentiation towards cardiac muscle lineages co-expressing Nkx2.5 marker. Furthermore, we have defined for the first time a detailed oxygen map during cardiac development finding that at early stages (E9.5) the whole primitive cardiac tube is hypoxic while from E12.5 to E14.5 low oxygen regions reside in the epicardium and endocardium with the intermediate myocardium remaining well oxygenated. HIF1 alpha expression within this time window follows a completely different pattern, suggesting that HIF1 alpha subunit stabilization during cardiogenesis occurs in an oxygen-independent manner. Indeed HIF1 alpha is spatial and temporaly regulated in a way that higher HIF1 alpha protein levels could be detected in the compct myocardium layer compared to the trabecules, composed by more mature cardiomyocytes in terms of structure and contractility. GOF and LOF models in Nkx2.5 mesodermal progenitors show different defects in chamber formation, beeing the deletion of VHL embryonic lethal in this pool of precursors. Transcriptional analysys from E12.5 hearts of GOF/LOF models suggests that HIF1 regulates bioenergetics of embryonic cardiomyocytes mediating a metabolic compartmentalization that programs glycolytic metabolism in the high HIF1 alpha -expressing compact myocardium and allows oxidative metabolism in the trabecules with lower HIF1 alpha levels. This hypothesis is further supported by the observation of differential mithocondrial netwrok and functional activity between both myocardial layer and the loss of this heterogeneous pattern in GOF/LOF models. In addition we have determine the role of hypoxia and HIF/VHL pathway in the biology of epicardial progenitors. We have generated a GOF model by deleting vhl in the Wt1 lineage that develops cardiac hypertrophy and present difused fibrosis, pericardial hemorrhages, miocarditis and severe dilatation of the coronaries. These mice show high lethality in the postnatal period and suddenly die pressumably by coronary rupture. Furthermore, recent studies indicate that these mice present systemic inflammation that could probably contribute to exacerbate the coronary vasculitis developed by these mice. In parallel we have generated a LOF model that demonstrate that the lack of HIF2 during heart formation is deleterious and induces myocardial dilatation and ventricular disfunction. These results show that a proper balance in HIF/VHL pathway is required for correct coronary development and cardiovascular homeostasis. In summary our data demonstrate that hypoxia and HIF/VHL axis participates in esential processes during mammalian cardiogenesis like ventricular chamber formation or coronary development. We are currently characterizing the molecular mechanisms underlying the alterations observed in the different phenotypes described above. We consider that the mouse model generated could have biomedical interest as they might recapitulates congenital heart disease and defects not fully understood, thus providing a perfect experimental scenario to understand the molecular origin of human pathologies and offering the opportunity to test novel diagnostic/therapeutic opportunities.
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
Cardiogenesis is a complex process that involves different cell types that have to mature to form the final functional heart compartments. Isl1 cardiovascular progenitors label the “second heart field” and contribute to myocardial, smooth muscle and endothelial structures of the heart. These progenitors have been extensively studied but little is know about the extracellular signals mediating their cell fate decisions and biology. A more recent group of cardiovascular progenitors arising from the epicardium and labeled by the expression of Tbx18 or Wt1 have been reported to contribute to the coronary arterial tree, cardiac fibroblasts and atrial and ventricular cardiomyocytes. Embryonic hypoxia has been involved in cardiovascular system development, while the molecular mechanisms controlling the adaptation to low oxygen tensions during heart formation remain poorly understood. Thus, I aim to determine if changes in the oxygen supply could regulate early cardiovascular progenitor’s proliferation, migration or commitment towards specific differentiated cardiac lineages and evaluate the concept of hypoxia as a potential niche for cardiovascular progenitors. We aim to study cellular properties and mechanisms that might be influenced by hypoxia as cell metabolism, transcriptional regulation and modulation of morphogenic signaling pathways. Several reporter embryonic stem cell lines will be used as in vitro systems to trace and isolate discrete pools of cardiovascular progenitors after exposure to different oxygen tensions and recapitulate cardiac development in a dish. Additionally in vivo mouse models of conditional deletion of hypoxia pathway elements (HIFs, VHL, PHDs) in cardiovascular progenitors will be employed to confirm the in vitro data and to determine of the role of hypoxia in early cardiogenesis. Unraveling these points could open a research avenue towards new methodologies in the cardiovascular stem cell field and may have therapeutic significance.
Оригинален текст от CORDIS (на английски).
Участници
- CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III (F.S.P.) · MadridКоординаторИспания
Връзки
Данни: CORDIS, © Европейски съюз
